Piperazine‐Functionalized Nanoparticles Enable Oral Insulin Delivery in Obese Mice
Advanced Science · 2026
DOI: 10.1002/advs.202520918 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yuxue Cao und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Pharmaceutical Sciences, The University of Queensland, Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: Insulin, Nanoparticles, Piperazines, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Gastroenterological Society for Australia, Australian Infectious Disease Research Centre.
Abstract (Originalsprache)
Biologics have gained prominence as a rapidly advancing therapeutic modality for a diverse spectrum of medical conditions. Nonetheless, they are predominantly administered parenterally due to poor absorption through the gastrointestinal tract. Additionally, repeated injections of biologics such as insulin cause injection pain, leading to dose‐skipping and poor medication adherence. Recently, our group and others have shown that nanoparticle‐based drug delivery systems enhance intestinal permeation and oral delivery of biologics such as insulin and exenatide. However, their effectiveness is not on par with chemical permeation enhancers (PEs) including fatty acids, lipids, and 1‐phenylpiperazine (PPZ), which are toxic at their effective doses. In this work, we report successful PPZ grafting onto silica nanoparticles with no apparent toxicity and significantly increased permeation of macromolecules such as insulin in an in vitro Caco‐2 monolayer model and a co‐culture model. In vivo experiments, with silica‐PPZ‐based novel PE improves the permeation of FITC‐dextran‐4 kDa in healthy mice compared to bare silica nanoparticles and macromolecule alone. In a high‐fat diet mouse model, the use of silica‐PPZ significantly enhances insulin absorption in the intestine. This led to markedly lower and more sustained blood glucose levels compared to controls without any associated toxicity to mice. Overall, we have shown, for the first time, that PPZ‐grafted silica nanoparticles can serve as a safe and effective permeation enhancer for the oral administration of insulin and potentially other biologics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Pharmaceutical Sciences, The University of Queensland, Brisbane, QLD, Australia.
- Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
- Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia.
- Immunopathology Group, Mater Research Institute, Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia.
- Centre for Advanced Imaging, The University of Queensland, QLD, Australia.
- School of Materials Science and Engineering, The University of New South Wales, Sydney, NSW, Australia.
Förderung
- National Health and Medical Research Council
- Gastroenterological Society for Australia
- Australian Infectious Disease Research Centre
Zitieren
APA
Cao, Y., Jiang, X., Moniruzzaman, M., Mueller, A., Janjua, T. I., Tyagi, N., Qu, Z., Wong, K. Y., Feng, Y., Ghodasara, A., Strounina, E., Ross, B. P., Kumeria, T., Hasnain, S. Z., & Popat, A. (2026). Piperazine‐Functionalized Nanoparticles Enable Oral Insulin Delivery in Obese Mice. Advanced Science. https://doi.org/10.1002/advs.202520918
Vancouver
Cao Y, Jiang X, Moniruzzaman M, Mueller A, Janjua TI, Tyagi N, et al. Piperazine‐Functionalized Nanoparticles Enable Oral Insulin Delivery in Obese Mice. Advanced Science. 2026. doi:10.1002/advs.202520918
BibTeX
@article{Cao2026,
author = {Cao, Yuxue and Jiang, Xiaofan and Moniruzzaman, Md and Mueller, Alexandra and Janjua, Taskeen Iqbal and Tyagi, Nisha and Qu, Zhi and Wong, Kuan Yau and Feng, Yuran and Ghodasara, Aayushi and Strounina, Ekaterina and Ross, Benjamin P and Kumeria, Tushar and Hasnain, Sumaira Z and Popat, Amirali},
title = {Piperazine‐Functionalized Nanoparticles Enable Oral Insulin Delivery in Obese Mice},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202520918}
}
EUVIMED